neurotrophic factor bdnf Search Results


94
Elabscience Biotechnology elisa kit
Fig. 2 Riluzole treatment restores <t>hippocampal</t> <t>BDNF</t> in the irradiated hippocampus. 10–12 weeks old WT male mice received cranial radiation therapy (RT) followed by riluzole (RZ) treatment (13 mg/kg) in drinking water for 6–7 weeks. An <t>ELISA-based</t> quantification of BDNF from the micro-dissected hippocampus showed RT-induced reductions in the RT + Vehicle group. Importantly, RZ treatment in the cranially irradiated mice showed significant restoration of BDNF levels. Data are presented as mean ± SEM (N = 6–10 mice per group). P values were derived from two-way ANOVA and Bonferroni’s multiple comparisons test
Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/neurotrophic+factor+bdnf/Mouse+BDNF+(Brain+Derived+Neurotrophic+Factor)+ELISA+Kit/pm39696694-109-8-11
Average 94 stars, based on 1 article reviews
elisa kit - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc snai1
Fig. 3. Suppression of treRNA by miR-190a inhibits EMT in HCC. (A) 20 nM miR-190a, 20 nM siRNA duplexes against treRNA (si-treRNA1 or sitreRNA2), 20 nM miR-190a, or NC RNA was transfected into Huh-7 or HepG2 cells. EMT related genes were quantified 72 h post-transfection as indicated. (B) Cells were treated with antagomiR (anti-miR- 190a) or NC RNA as in (A). The mRNA level of different EMT genes was quantified and normalized to b-actin. (C) Cell lysates were blotting with EMT marker E-cadherin (E-cad), Claudin-1 (Claud), Vimentin (Vimen), N-cadherin (N-cad), <t>SNAI1</t> (Snail). b-Actin was used as endogenous control. The EMT marker expression level in was calculated using Image J and presented as histogram (right panel). (D) Cells were treated with TGF-b for 12 h and transfected with 20 nM miR-190a, 20 nM siRNA duplexes against treRNA (si-treRNA1 or si-treRNA2) or NC RNA subsequently. The morphological change was captured 24 h after transfection.
Snai1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/neurotrophic+factor+bdnf/Human+Brain-Derived+Neurotrophic+Factor/pm26608035-65-47-49
Average 93 stars, based on 1 article reviews
snai1 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

92
ABclonal Biotechnology bdnf f
Fig. 3. Suppression of treRNA by miR-190a inhibits EMT in HCC. (A) 20 nM miR-190a, 20 nM siRNA duplexes against treRNA (si-treRNA1 or sitreRNA2), 20 nM miR-190a, or NC RNA was transfected into Huh-7 or HepG2 cells. EMT related genes were quantified 72 h post-transfection as indicated. (B) Cells were treated with antagomiR (anti-miR- 190a) or NC RNA as in (A). The mRNA level of different EMT genes was quantified and normalized to b-actin. (C) Cell lysates were blotting with EMT marker E-cadherin (E-cad), Claudin-1 (Claud), Vimentin (Vimen), N-cadherin (N-cad), <t>SNAI1</t> (Snail). b-Actin was used as endogenous control. The EMT marker expression level in was calculated using Image J and presented as histogram (right panel). (D) Cells were treated with TGF-b for 12 h and transfected with 20 nM miR-190a, 20 nM siRNA duplexes against treRNA (si-treRNA1 or si-treRNA2) or NC RNA subsequently. The morphological change was captured 24 h after transfection.
Bdnf F, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/neurotrophic+factor+bdnf/Human+Brain+Derived+Neurotrophic+Factor+ELISA+Kit/pmc10603561-176-0-3
Average 92 stars, based on 1 article reviews
bdnf f - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

93
Boster Bio bdnf
Effect of silibinin administration on A <t>BDNF</t> (ng/ml) and <t>B</t> <t>CaMKII</t> (ng/mg) in sleep-deprived rats with and without consequent 24-h recovery. Data are represented as mean ± SD ( n = 8); group comparisons were performed using one-way ANOVA, followed by Tukey’s multiple-comparisons test. * P < 0.05, ** P < 0.01, and *** P < 0.001 versus the control group; $ P < 0.05, $$ P < 0.01, and $$$ P < 0.001 versus the SD group; # P < 0.05, ## P < 0.01, and ### P < 0.001 versus the SD + R group. SD: sleep-deprived untreated group; SD + R: sleep-deprived untreated group with recovery; SD + Sil: sleep-deprived group treated with silibinin; SD + Sil + R: sleep-deprived group treated with silibinin followed by recovery. BDNF: brain‑derived neurotrophic factor; CaMKII: calcium/calmodulin‑dependent protein kinase II
Bdnf, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/neurotrophic+factor+bdnf/Rat+BDNF+ELISA+Kit+PicoKine/pmc13633991-112-8-9
Average 93 stars, based on 1 article reviews
bdnf - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
Alomone Labs biotinylated bdnf
TRKB and cholesterol interaction. (a,b) Snapshots of the interaction between TRKB and cholesterol at the TMR (see supplement video) indicating that cholesterol interacts with the OH- group (red) in Y433 (blue) in TRKB.TMR (green). (c) The interaction between the TRKB CARC motif and cholesterol happens preferentially at the C-alpha in Y433 residues, as indicated by coarse-grained molecular dynamics simulations. (d) The binding of <t>biotinylated</t> <t>BDNF</t> (bBDNF) and TRKB is modulated by cholesterol in a bell-shaped fashion. Red rectangle area is expanded in (e) for the comparison between BDNF 1ng/ml (black circles) with BDNF 0 (ctrl, open circles). Data expressed as Mean/SEM of (c) cholesterol occupancy; or from binding normalized by (d) chol 0/BDNF10ng/ml or (e) chol 0/BDNF 1ng/ml. ∗p<0.05 from control (BDNF 0 or ctrl, C427).
Biotinylated Bdnf, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/neurotrophic+factor+bdnf/human+BDNF-Biotin/bio_rxiv__734012-71-12-20
Average 94 stars, based on 1 article reviews
biotinylated bdnf - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

96
Alomone Labs brain derived neurotrophic factor bdnf
TRKB and cholesterol interaction. (a,b) Snapshots of the interaction between TRKB and cholesterol at the TMR (see supplement video) indicating that cholesterol interacts with the OH- group (red) in Y433 (blue) in TRKB.TMR (green). (c) The interaction between the TRKB CARC motif and cholesterol happens preferentially at the C-alpha in Y433 residues, as indicated by coarse-grained molecular dynamics simulations. (d) The binding of <t>biotinylated</t> <t>BDNF</t> (bBDNF) and TRKB is modulated by cholesterol in a bell-shaped fashion. Red rectangle area is expanded in (e) for the comparison between BDNF 1ng/ml (black circles) with BDNF 0 (ctrl, open circles). Data expressed as Mean/SEM of (c) cholesterol occupancy; or from binding normalized by (d) chol 0/BDNF10ng/ml or (e) chol 0/BDNF 1ng/ml. ∗p<0.05 from control (BDNF 0 or ctrl, C427).
Brain Derived Neurotrophic Factor Bdnf, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/neurotrophic+factor+bdnf/Anti-BDNF+Antibody/pmc12147987-346-50-57
Average 96 stars, based on 1 article reviews
brain derived neurotrophic factor bdnf - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

94
Alomone Labs anti trkb
TRKB and cholesterol interaction. (a,b) Snapshots of the interaction between TRKB and cholesterol at the TMR (see supplement video) indicating that cholesterol interacts with the OH- group (red) in Y433 (blue) in TRKB.TMR (green). (c) The interaction between the TRKB CARC motif and cholesterol happens preferentially at the C-alpha in Y433 residues, as indicated by coarse-grained molecular dynamics simulations. (d) The binding of <t>biotinylated</t> <t>BDNF</t> (bBDNF) and TRKB is modulated by cholesterol in a bell-shaped fashion. Red rectangle area is expanded in (e) for the comparison between BDNF 1ng/ml (black circles) with BDNF 0 (ctrl, open circles). Data expressed as Mean/SEM of (c) cholesterol occupancy; or from binding normalized by (d) chol 0/BDNF10ng/ml or (e) chol 0/BDNF 1ng/ml. ∗p<0.05 from control (BDNF 0 or ctrl, C427).
Anti Trkb, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/neurotrophic+factor+bdnf/Anti-TrkB+(extracellular)+Antibody/pmc04353718-59-0-2
Average 94 stars, based on 1 article reviews
anti trkb - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

90
Alomone Labs recombinant bdnfpro
Fig. 2 subcellular localization of <t>BDNFpro.</t> a Graphical representation of the SIM super-resolution microscope. 3D-SIM image of a GFP-labeled astrocyte in a TBS-slice from control mice. Scale bar: 10 µm. Magnification of a ROI shows BDNFpro/GFP colocalization signal localized in fine membrane extensions of the cell periphery. Scale bar: 200 nm. b 3D-SIM image of the ROI in (a); z-axe is visualized in pseudocolor to facilitate microdomains identification. Scale bar: 200 nm. Magnification of microdomains characterized by the typical fingerlike extension (dashed squares 1 and 2) and flat lamellar sheath (dashed squares 3 and 4) are shown. BDNFpro/GFP colocalization is indicated (red arrowheads). Scale bars: 40 nm.
Recombinant Bdnfpro, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/neurotrophic+factor+bdnf/Recombinant+human+BDNF+proDomain+protein/pm34611268-373-3-7
Average 90 stars, based on 1 article reviews
recombinant bdnfpro - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

96
Alomone Labs b 250

B 250, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/neurotrophic+factor+bdnf/Recombinant+human+BDNF+protein/pmc11338522-29-8-5
Average 96 stars, based on 1 article reviews
b 250 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

95
Elabscience Biotechnology brain derived neurotrophic factor

Brain Derived Neurotrophic Factor, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/neurotrophic+factor+bdnf/Rat+BDNF+(Brain+Derived+Neurotrophic+Factor)+ELISA+Kit/pm39820866-86-24-29
Average 95 stars, based on 1 article reviews
brain derived neurotrophic factor - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
Elabscience Biotechnology enzymelinked immunosorbent assay kit

Enzymelinked Immunosorbent Assay Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/neurotrophic+factor+bdnf/Human+BDNF+(Brain+Derived+Neurotrophic+Factor)+ELISA+Kit/pmc10981270-90-8-12
Average 94 stars, based on 1 article reviews
enzymelinked immunosorbent assay kit - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

91
ABclonal Biotechnology elisa kits

Elisa Kits, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/neurotrophic+factor+bdnf/Mouse+Brain+Derived+Neurotrophic+Factor+ELISA+Kit/pmc06714227__JCMM___23___6512___s001-3-0-11
Average 91 stars, based on 1 article reviews
elisa kits - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

Image Search Results


Fig. 2 Riluzole treatment restores hippocampal BDNF in the irradiated hippocampus. 10–12 weeks old WT male mice received cranial radiation therapy (RT) followed by riluzole (RZ) treatment (13 mg/kg) in drinking water for 6–7 weeks. An ELISA-based quantification of BDNF from the micro-dissected hippocampus showed RT-induced reductions in the RT + Vehicle group. Importantly, RZ treatment in the cranially irradiated mice showed significant restoration of BDNF levels. Data are presented as mean ± SEM (N = 6–10 mice per group). P values were derived from two-way ANOVA and Bonferroni’s multiple comparisons test

Journal: Acta neuropathologica communications

Article Title: BDNF augmentation reverses cranial radiation therapy-induced cognitive decline and neurodegenerative consequences.

doi: 10.1186/s40478-024-01906-9

Figure Lengend Snippet: Fig. 2 Riluzole treatment restores hippocampal BDNF in the irradiated hippocampus. 10–12 weeks old WT male mice received cranial radiation therapy (RT) followed by riluzole (RZ) treatment (13 mg/kg) in drinking water for 6–7 weeks. An ELISA-based quantification of BDNF from the micro-dissected hippocampus showed RT-induced reductions in the RT + Vehicle group. Importantly, RZ treatment in the cranially irradiated mice showed significant restoration of BDNF levels. Data are presented as mean ± SEM (N = 6–10 mice per group). P values were derived from two-way ANOVA and Bonferroni’s multiple comparisons test

Article Snippet: BDNF levels were quantified using a commercially available ELISA kit (E-EL-M0203, Elabscience Biotechnology) and uncoated ELISA plates (Nunc MaxiSorp, Biolegend).

Techniques: Irradiation, Enzyme-linked Immunosorbent Assay, Derivative Assay

Fig. 3. Suppression of treRNA by miR-190a inhibits EMT in HCC. (A) 20 nM miR-190a, 20 nM siRNA duplexes against treRNA (si-treRNA1 or sitreRNA2), 20 nM miR-190a, or NC RNA was transfected into Huh-7 or HepG2 cells. EMT related genes were quantified 72 h post-transfection as indicated. (B) Cells were treated with antagomiR (anti-miR- 190a) or NC RNA as in (A). The mRNA level of different EMT genes was quantified and normalized to b-actin. (C) Cell lysates were blotting with EMT marker E-cadherin (E-cad), Claudin-1 (Claud), Vimentin (Vimen), N-cadherin (N-cad), SNAI1 (Snail). b-Actin was used as endogenous control. The EMT marker expression level in was calculated using Image J and presented as histogram (right panel). (D) Cells were treated with TGF-b for 12 h and transfected with 20 nM miR-190a, 20 nM siRNA duplexes against treRNA (si-treRNA1 or si-treRNA2) or NC RNA subsequently. The morphological change was captured 24 h after transfection.

Journal: FEBS letters

Article Title: miR-190a inhibits epithelial-mesenchymal transition of hepatoma cells via targeting the long non-coding RNA treRNA.

doi: 10.1016/j.febslet.2015.11.024

Figure Lengend Snippet: Fig. 3. Suppression of treRNA by miR-190a inhibits EMT in HCC. (A) 20 nM miR-190a, 20 nM siRNA duplexes against treRNA (si-treRNA1 or sitreRNA2), 20 nM miR-190a, or NC RNA was transfected into Huh-7 or HepG2 cells. EMT related genes were quantified 72 h post-transfection as indicated. (B) Cells were treated with antagomiR (anti-miR- 190a) or NC RNA as in (A). The mRNA level of different EMT genes was quantified and normalized to b-actin. (C) Cell lysates were blotting with EMT marker E-cadherin (E-cad), Claudin-1 (Claud), Vimentin (Vimen), N-cadherin (N-cad), SNAI1 (Snail). b-Actin was used as endogenous control. The EMT marker expression level in was calculated using Image J and presented as histogram (right panel). (D) Cells were treated with TGF-b for 12 h and transfected with 20 nM miR-190a, 20 nM siRNA duplexes against treRNA (si-treRNA1 or si-treRNA2) or NC RNA subsequently. The morphological change was captured 24 h after transfection.

Article Snippet: Membranes were blocked by 5% BSA or 5% non-fat milk for 3 h at 25 C and incubated with primary antibody against Ago2 (#2897, Cell Signaling, US), Dicer (#5362, Cell Signaling), E-Cadherin (#3195, Cell Signaling), Claudin-1 (#13255, Cell Signaling), Vimentin (#5741, Cell Signaling), N-Cadherin (#13116, Cell Signaling), SNAI1 (#3897, Cell Signaling), or b-actin (C-4, Santa cruz, US) for 12 h at 4 C. Membranes were incubated with secondary antibody diluted in Tris-buffered saline supplemented with 0.5% Tween-20 and 5% BSA or 5% non-fat milk for 1 h at 25 C. The signal was detected with the enhanced chemiluminescence system (Pierce, US) and exposed to X-ray film (Kodak, US).

Techniques: Transfection, Marker, Control, Expressing

Effect of silibinin administration on A BDNF (ng/ml) and B CaMKII (ng/mg) in sleep-deprived rats with and without consequent 24-h recovery. Data are represented as mean ± SD ( n = 8); group comparisons were performed using one-way ANOVA, followed by Tukey’s multiple-comparisons test. * P < 0.05, ** P < 0.01, and *** P < 0.001 versus the control group; $ P < 0.05, $$ P < 0.01, and $$$ P < 0.001 versus the SD group; # P < 0.05, ## P < 0.01, and ### P < 0.001 versus the SD + R group. SD: sleep-deprived untreated group; SD + R: sleep-deprived untreated group with recovery; SD + Sil: sleep-deprived group treated with silibinin; SD + Sil + R: sleep-deprived group treated with silibinin followed by recovery. BDNF: brain‑derived neurotrophic factor; CaMKII: calcium/calmodulin‑dependent protein kinase II

Journal: Molecular Neurobiology

Article Title: Silibinin Alleviates Cognitive Dysfunction, Biochemical Alterations, and Hippocampal Structural Changes Induced by 5 days of Sleep Deprivation with or Without a Subsequent 24-H Recovery in Rats

doi: 10.1007/s12035-026-06195-y

Figure Lengend Snippet: Effect of silibinin administration on A BDNF (ng/ml) and B CaMKII (ng/mg) in sleep-deprived rats with and without consequent 24-h recovery. Data are represented as mean ± SD ( n = 8); group comparisons were performed using one-way ANOVA, followed by Tukey’s multiple-comparisons test. * P < 0.05, ** P < 0.01, and *** P < 0.001 versus the control group; $ P < 0.05, $$ P < 0.01, and $$$ P < 0.001 versus the SD group; # P < 0.05, ## P < 0.01, and ### P < 0.001 versus the SD + R group. SD: sleep-deprived untreated group; SD + R: sleep-deprived untreated group with recovery; SD + Sil: sleep-deprived group treated with silibinin; SD + Sil + R: sleep-deprived group treated with silibinin followed by recovery. BDNF: brain‑derived neurotrophic factor; CaMKII: calcium/calmodulin‑dependent protein kinase II

Article Snippet: Furthermore, hippocampal tissue homogenates were prepared to determine BDNF (Boster Biological Technology, Pleasanton, CA, USA; Cat. No. EK0308) and CaMKII (BlueGene Biotech, Shanghai, China; Cat. No. E02C0682) using commercially available ELISA kits supplied by Bio-KITS (Cairo, Egypt), according to the manufacturers' instructions.

Techniques: Control

TRKB and cholesterol interaction. (a,b) Snapshots of the interaction between TRKB and cholesterol at the TMR (see supplement video) indicating that cholesterol interacts with the OH- group (red) in Y433 (blue) in TRKB.TMR (green). (c) The interaction between the TRKB CARC motif and cholesterol happens preferentially at the C-alpha in Y433 residues, as indicated by coarse-grained molecular dynamics simulations. (d) The binding of biotinylated BDNF (bBDNF) and TRKB is modulated by cholesterol in a bell-shaped fashion. Red rectangle area is expanded in (e) for the comparison between BDNF 1ng/ml (black circles) with BDNF 0 (ctrl, open circles). Data expressed as Mean/SEM of (c) cholesterol occupancy; or from binding normalized by (d) chol 0/BDNF10ng/ml or (e) chol 0/BDNF 1ng/ml. ∗p<0.05 from control (BDNF 0 or ctrl, C427).

Journal: bioRxiv

Article Title: Cholesterol recognition motifs in the transmembrane domain of the tyrosine kinase receptor family: the case for TRKB

doi: 10.1101/734012

Figure Lengend Snippet: TRKB and cholesterol interaction. (a,b) Snapshots of the interaction between TRKB and cholesterol at the TMR (see supplement video) indicating that cholesterol interacts with the OH- group (red) in Y433 (blue) in TRKB.TMR (green). (c) The interaction between the TRKB CARC motif and cholesterol happens preferentially at the C-alpha in Y433 residues, as indicated by coarse-grained molecular dynamics simulations. (d) The binding of biotinylated BDNF (bBDNF) and TRKB is modulated by cholesterol in a bell-shaped fashion. Red rectangle area is expanded in (e) for the comparison between BDNF 1ng/ml (black circles) with BDNF 0 (ctrl, open circles). Data expressed as Mean/SEM of (c) cholesterol occupancy; or from binding normalized by (d) chol 0/BDNF10ng/ml or (e) chol 0/BDNF 1ng/ml. ∗p<0.05 from control (BDNF 0 or ctrl, C427).

Article Snippet: The plates were washed 3x with PBS buffer, and a mixture of biotinylated BDNF (bBDNF, 0, 0.1, 1 or 10ng/ml, Alomone Labs, #B-250-B) and cholesterol (0, 20, 50 or 100μM) was added for 1h at room temperature, followed by washing with PBS.

Techniques: Binding Assay, Comparison, Control

Fig. 2 subcellular localization of BDNFpro. a Graphical representation of the SIM super-resolution microscope. 3D-SIM image of a GFP-labeled astrocyte in a TBS-slice from control mice. Scale bar: 10 µm. Magnification of a ROI shows BDNFpro/GFP colocalization signal localized in fine membrane extensions of the cell periphery. Scale bar: 200 nm. b 3D-SIM image of the ROI in (a); z-axe is visualized in pseudocolor to facilitate microdomains identification. Scale bar: 200 nm. Magnification of microdomains characterized by the typical fingerlike extension (dashed squares 1 and 2) and flat lamellar sheath (dashed squares 3 and 4) are shown. BDNFpro/GFP colocalization is indicated (red arrowheads). Scale bars: 40 nm.

Journal: Communications biology

Article Title: Astrocytic microdomains from mouse cortex gain molecular control over long-term information storage and memory retention.

doi: 10.1038/s42003-021-02678-x

Figure Lengend Snippet: Fig. 2 subcellular localization of BDNFpro. a Graphical representation of the SIM super-resolution microscope. 3D-SIM image of a GFP-labeled astrocyte in a TBS-slice from control mice. Scale bar: 10 µm. Magnification of a ROI shows BDNFpro/GFP colocalization signal localized in fine membrane extensions of the cell periphery. Scale bar: 200 nm. b 3D-SIM image of the ROI in (a); z-axe is visualized in pseudocolor to facilitate microdomains identification. Scale bar: 200 nm. Magnification of microdomains characterized by the typical fingerlike extension (dashed squares 1 and 2) and flat lamellar sheath (dashed squares 3 and 4) are shown. BDNFpro/GFP colocalization is indicated (red arrowheads). Scale bars: 40 nm.

Article Snippet: In some experiments, recombinant BDNFpro (10 ng/ml; Alomone Labs, Cat#B245), BDNFproVal/Met (10 ng/ml; Alomone Labs, Cat#B-445), mBDNF (10 ng/ml; Laboratory of Antonino Cattaneo, SNS, Pisa, Italy), and proBDNFCR (20 ng/ml; Laboratory of Antonino Cattaneo, SNS, Pisa, Italy) were perfused into a recording chamber.

Techniques: Super-Resolution Microscopy, Labeling, Control, Membrane

Fig. 3 localization of BDNFpro in astrocytic microdomains. a Experimental design linking field-potential with electron microscopy (EM) in layer II/III perirhinal cortex. TBS (10 min)-slices were dissected for EM processing. b Representative EM-image depicts BDNFpro-gold particles at axon bouton (dashed squares 1 to 4) and dendritic spine (dashed squares 5 and 6). Scale bar: 100 nm. Magnification indicates representative areas (dashed squares 1 to 6) in which gold particles (red arrowheads) localization is shown. Scale bars: 10 nm. c Representative EM-image depicts BDNFpro-gold particles (dashed squares 1 to 6) at astrocytic microdomains (light blue) Scale bar: 250 nm. Magnification indicates representative areas (dashed squares 1 to 6) in which gold particles (red arrowheads) localization is shown. Scale bars: 20 nm. d Dot plot depicts the number of BDNFpro-gold particles in whole astrocytes and peri-synaptic astrocytes counted per section (n = 41 sections, 5 slices, 3 mice). e Dot plot depicts the percentage of BDNFpro-gold particles at peri-synaptic astrocytes (n = 41 sections, 5 slices, 3 mice). Data are mean ± SEM.

Journal: Communications biology

Article Title: Astrocytic microdomains from mouse cortex gain molecular control over long-term information storage and memory retention.

doi: 10.1038/s42003-021-02678-x

Figure Lengend Snippet: Fig. 3 localization of BDNFpro in astrocytic microdomains. a Experimental design linking field-potential with electron microscopy (EM) in layer II/III perirhinal cortex. TBS (10 min)-slices were dissected for EM processing. b Representative EM-image depicts BDNFpro-gold particles at axon bouton (dashed squares 1 to 4) and dendritic spine (dashed squares 5 and 6). Scale bar: 100 nm. Magnification indicates representative areas (dashed squares 1 to 6) in which gold particles (red arrowheads) localization is shown. Scale bars: 10 nm. c Representative EM-image depicts BDNFpro-gold particles (dashed squares 1 to 6) at astrocytic microdomains (light blue) Scale bar: 250 nm. Magnification indicates representative areas (dashed squares 1 to 6) in which gold particles (red arrowheads) localization is shown. Scale bars: 20 nm. d Dot plot depicts the number of BDNFpro-gold particles in whole astrocytes and peri-synaptic astrocytes counted per section (n = 41 sections, 5 slices, 3 mice). e Dot plot depicts the percentage of BDNFpro-gold particles at peri-synaptic astrocytes (n = 41 sections, 5 slices, 3 mice). Data are mean ± SEM.

Article Snippet: In some experiments, recombinant BDNFpro (10 ng/ml; Alomone Labs, Cat#B245), BDNFproVal/Met (10 ng/ml; Alomone Labs, Cat#B-445), mBDNF (10 ng/ml; Laboratory of Antonino Cattaneo, SNS, Pisa, Italy), and proBDNFCR (20 ng/ml; Laboratory of Antonino Cattaneo, SNS, Pisa, Italy) were perfused into a recording chamber.

Techniques: Electron Microscopy

Fig. 4 vesicular localization of BDNFpro. a z-stack reconstruction shows astrocytes labeled by GFP. Cortical slices from control mice injected with AAV- GFAP-GFP virus were fixed 10 min after TBS and processed for immunostaining and confocal analysis. Scale bar: 10 µm. Magnification of a ROI shows one GFP-astrocyte delimited by an approximate territory (white dashed). Scale bar: 10 µm. BDNFpro/GFP and Vamp2/GFP co-localizations signals are shown. Magnification shows representative areas (dashed squares 1 to 4) in which BDNFpro/GFP and Vamp2/GFP signals overlap. Scale bars: 1 µm. b 3D-SIM image of a GFP-labeled astrocyte in a TBS-slice from control mice. Scale bar: 10 µm. Magnification of a ROI shows BDNFpro/Vamp2 colocalization signal. Scale bar: 500 nm. Magnification shows BDNFpro/Vamp2 colocalization signal in fine membrane extensions of the cell periphery (dashed squares 1 to 4). Scale bars: 50 nm. c EM image depicts BDNFpro-gold at astrocytic microdomains (light blue) surrounding an axon bouton. Scale bar: 100 nm. Magnification of the ROI shows gold particles (red arrowheads) in vesicular-like structures. Scale bar: 20 nm. d Digital reconstruction of the image in (c). Astrocytic vesicles (black boundary) are shown.

Journal: Communications biology

Article Title: Astrocytic microdomains from mouse cortex gain molecular control over long-term information storage and memory retention.

doi: 10.1038/s42003-021-02678-x

Figure Lengend Snippet: Fig. 4 vesicular localization of BDNFpro. a z-stack reconstruction shows astrocytes labeled by GFP. Cortical slices from control mice injected with AAV- GFAP-GFP virus were fixed 10 min after TBS and processed for immunostaining and confocal analysis. Scale bar: 10 µm. Magnification of a ROI shows one GFP-astrocyte delimited by an approximate territory (white dashed). Scale bar: 10 µm. BDNFpro/GFP and Vamp2/GFP co-localizations signals are shown. Magnification shows representative areas (dashed squares 1 to 4) in which BDNFpro/GFP and Vamp2/GFP signals overlap. Scale bars: 1 µm. b 3D-SIM image of a GFP-labeled astrocyte in a TBS-slice from control mice. Scale bar: 10 µm. Magnification of a ROI shows BDNFpro/Vamp2 colocalization signal. Scale bar: 500 nm. Magnification shows BDNFpro/Vamp2 colocalization signal in fine membrane extensions of the cell periphery (dashed squares 1 to 4). Scale bars: 50 nm. c EM image depicts BDNFpro-gold at astrocytic microdomains (light blue) surrounding an axon bouton. Scale bar: 100 nm. Magnification of the ROI shows gold particles (red arrowheads) in vesicular-like structures. Scale bar: 20 nm. d Digital reconstruction of the image in (c). Astrocytic vesicles (black boundary) are shown.

Article Snippet: In some experiments, recombinant BDNFpro (10 ng/ml; Alomone Labs, Cat#B245), BDNFproVal/Met (10 ng/ml; Alomone Labs, Cat#B-445), mBDNF (10 ng/ml; Laboratory of Antonino Cattaneo, SNS, Pisa, Italy), and proBDNFCR (20 ng/ml; Laboratory of Antonino Cattaneo, SNS, Pisa, Italy) were perfused into a recording chamber.

Techniques: Labeling, Control, Injection, Virus, Immunostaining, Confocal, Analysis, Membrane

Fig. 6 post-synaptic targeting of TrkB/SorCS2 complex. a Schematic representation of the experimental design. Circular DNA probes (−) and (+) are coupled to II° antibody targeting αSorCS2 and αTrkB I° antibody. BDNFpro induces TrkB/SorCS2 complex formation (PLATrkB/SorCS2) that is prevented in the presence of αSorCS2 (blocking) antibody. b Panels show PLATrkB/SorCS2 signals in primary culture of cortical neurons treated with vehicle or BDNFpro. The insets show reference GFP-neurons. Scale bars: 5 μm. c Panels show a GFP-neuron treated with BDNFpro. Scale bar: 5 μm. Magnification of regions of interest 1 and 2 shows dendritic PLATrkB/SorCS2 localization (red arrowheads). Scale bar: 1 μm. d Quantification of PLATrkB/SorCS2 signal in cultured neurons treated with vehicle, BDNFpro (in presence or absence of αSorCS2), mBDNF or proBDNFCR. Data are presented as mean ± SEM; **p < 0.01 (unpaired t- test) (n = 111 cells, 3 cultures for vehicle; n = 152 cells, 4 cultures for BDNFpro; n = 98 cells, 3 cultures for BDNFpro/aSorCS2; n = 89 cells, 3 cultures for mBDNF; n = 79 cells, 3 cultures for proBDNFCR). e z-stack reconstruction showing NeuN, PSD95 and PLATrkB/SorCS2 signals in baseline and TBS slices. NeuN/PLATrkB/SorCS2 and PSD95/PLATrkB/SorCS2 colocalization signals are shown. Scale bars: 40 μm. NeuN/PLATrkB/SorCS2 and PSD95/PLATrkB/SorCS2

Journal: Communications biology

Article Title: Astrocytic microdomains from mouse cortex gain molecular control over long-term information storage and memory retention.

doi: 10.1038/s42003-021-02678-x

Figure Lengend Snippet: Fig. 6 post-synaptic targeting of TrkB/SorCS2 complex. a Schematic representation of the experimental design. Circular DNA probes (−) and (+) are coupled to II° antibody targeting αSorCS2 and αTrkB I° antibody. BDNFpro induces TrkB/SorCS2 complex formation (PLATrkB/SorCS2) that is prevented in the presence of αSorCS2 (blocking) antibody. b Panels show PLATrkB/SorCS2 signals in primary culture of cortical neurons treated with vehicle or BDNFpro. The insets show reference GFP-neurons. Scale bars: 5 μm. c Panels show a GFP-neuron treated with BDNFpro. Scale bar: 5 μm. Magnification of regions of interest 1 and 2 shows dendritic PLATrkB/SorCS2 localization (red arrowheads). Scale bar: 1 μm. d Quantification of PLATrkB/SorCS2 signal in cultured neurons treated with vehicle, BDNFpro (in presence or absence of αSorCS2), mBDNF or proBDNFCR. Data are presented as mean ± SEM; **p < 0.01 (unpaired t- test) (n = 111 cells, 3 cultures for vehicle; n = 152 cells, 4 cultures for BDNFpro; n = 98 cells, 3 cultures for BDNFpro/aSorCS2; n = 89 cells, 3 cultures for mBDNF; n = 79 cells, 3 cultures for proBDNFCR). e z-stack reconstruction showing NeuN, PSD95 and PLATrkB/SorCS2 signals in baseline and TBS slices. NeuN/PLATrkB/SorCS2 and PSD95/PLATrkB/SorCS2 colocalization signals are shown. Scale bars: 40 μm. NeuN/PLATrkB/SorCS2 and PSD95/PLATrkB/SorCS2

Article Snippet: In some experiments, recombinant BDNFpro (10 ng/ml; Alomone Labs, Cat#B245), BDNFproVal/Met (10 ng/ml; Alomone Labs, Cat#B-445), mBDNF (10 ng/ml; Laboratory of Antonino Cattaneo, SNS, Pisa, Italy), and proBDNFCR (20 ng/ml; Laboratory of Antonino Cattaneo, SNS, Pisa, Italy) were perfused into a recording chamber.

Techniques: Blocking Assay, Cell Culture, Immunofluorescence

Fig. 7 BDNFpro-induced TrkB/SorCS2 targeting. a Schematic representation of the experimental design. Step I, deletion of p75NTR in astrocytes from tamoxifen-treated p75-flox mice precludes proBDNF transfer from neurons to astrocyte following TBS. Step II, LV-BDNFprostop transduction replaces BDNFpro in astrocytes. Step III, astrocytic BDNFpro provides final increase of TrkB/SorCS2 complexes in dendritic spines and LTP maintenance. b z-stack reconstruction showing NeuN/PLATrkB/SorCS2 colocalization signal in TBS-slices from p75-flox mice transduced with LV-GFPstop or LV-BDNFprostop. Scale bars: 40 μm. The insets show the field of analysis. Scale bars: 15 μm. NeuN/PLATrkB/SorCS2 colocalization was quantified using Mander’s overlap. **p < 0.01 (unpaired t-test) (n = 4 slices, 3 mice for each experimental condition). c Dot plot shows quantification of pTrkB/TrkB colocalization in baseline- and TBS- slices from p75-flox mice transduced with LV-GFPstop or LV-BDNFprostop and control littermates using Mander’s overlap. ***p < 0.001 (unpaired t-test) (n = 4 slices, 3 mice for p75-flox mice/LV-GFPstop/TBS; n = 4 slices, 3 mice for p75-flox mice/LV-GFPstop/baseline; n = 6 slices, 4 mice for p75-flox mice/ LV-BDNFprostop/TBS; n = 5 slices, 4 mice for p75-flox mice/LV-BDNFprostop/baseline; n = 5 slices, 3 mice for control littermates/TBS; n = 6 slices, 3 mice for control littermates/baseline). Data are normalized to baseline and presented as mean ± SEM.

Journal: Communications biology

Article Title: Astrocytic microdomains from mouse cortex gain molecular control over long-term information storage and memory retention.

doi: 10.1038/s42003-021-02678-x

Figure Lengend Snippet: Fig. 7 BDNFpro-induced TrkB/SorCS2 targeting. a Schematic representation of the experimental design. Step I, deletion of p75NTR in astrocytes from tamoxifen-treated p75-flox mice precludes proBDNF transfer from neurons to astrocyte following TBS. Step II, LV-BDNFprostop transduction replaces BDNFpro in astrocytes. Step III, astrocytic BDNFpro provides final increase of TrkB/SorCS2 complexes in dendritic spines and LTP maintenance. b z-stack reconstruction showing NeuN/PLATrkB/SorCS2 colocalization signal in TBS-slices from p75-flox mice transduced with LV-GFPstop or LV-BDNFprostop. Scale bars: 40 μm. The insets show the field of analysis. Scale bars: 15 μm. NeuN/PLATrkB/SorCS2 colocalization was quantified using Mander’s overlap. **p < 0.01 (unpaired t-test) (n = 4 slices, 3 mice for each experimental condition). c Dot plot shows quantification of pTrkB/TrkB colocalization in baseline- and TBS- slices from p75-flox mice transduced with LV-GFPstop or LV-BDNFprostop and control littermates using Mander’s overlap. ***p < 0.001 (unpaired t-test) (n = 4 slices, 3 mice for p75-flox mice/LV-GFPstop/TBS; n = 4 slices, 3 mice for p75-flox mice/LV-GFPstop/baseline; n = 6 slices, 4 mice for p75-flox mice/ LV-BDNFprostop/TBS; n = 5 slices, 4 mice for p75-flox mice/LV-BDNFprostop/baseline; n = 5 slices, 3 mice for control littermates/TBS; n = 6 slices, 3 mice for control littermates/baseline). Data are normalized to baseline and presented as mean ± SEM.

Article Snippet: In some experiments, recombinant BDNFpro (10 ng/ml; Alomone Labs, Cat#B245), BDNFproVal/Met (10 ng/ml; Alomone Labs, Cat#B-445), mBDNF (10 ng/ml; Laboratory of Antonino Cattaneo, SNS, Pisa, Italy), and proBDNFCR (20 ng/ml; Laboratory of Antonino Cattaneo, SNS, Pisa, Italy) were perfused into a recording chamber.

Techniques: Transduction, Analysis, Control

Journal: Developmental Cell

Article Title: Axonal endoplasmic reticulum tubules control local translation via P180/RRBP1-mediated ribosome interactions

doi: 10.1016/j.devcel.2024.05.005

Figure Lengend Snippet:

Article Snippet: recombinant human BDNF protein , Alomone Labs , B-250.

Techniques: Recombinant